Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range T Battelino, T Danne, RM Bergenstal, SA Amiel, R Beck, T Biester, E Bosi, ... Diabetes care 42 (8), 1593-1603, 2019 | 3500 | 2019 |
Type 1 diabetes mellitus A Katsarou, S Gudbjörnsdottir, A Rawshani, D Dabelea, E Bonifacio, ... Nature reviews Disease primers 3 (1), 1-17, 2017 | 1688 | 2017 |
Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association RA Insel, JL Dunne, MA Atkinson, JL Chiang, D Dabelea, PA Gottlieb, ... Diabetes care 38 (10), 1964-1974, 2015 | 1217 | 2015 |
Rituximab, B-lymphocyte depletion, and preservation of beta-cell function MD Pescovitz, CJ Greenbaum, H Krause-Steinrauf, DJ Becker, ... New England Journal of Medicine 361 (22), 2143-2152, 2009 | 1190 | 2009 |
Differentiation of diabetes by pathophysiology, natural history, and prognosis JS Skyler, GL Bakris, E Bonifacio, T Darsow, RH Eckel, L Groop, ... Diabetes 66 (2), 241-255, 2017 | 1181 | 2017 |
Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells VK Ramiya, M Maraist, KE Arfors, DA Schatz, AB Peck, JG Cornelius Nature medicine 6 (3), 278-282, 2000 | 1156 | 2000 |
Toward defining the autoimmune microbiome for type 1 diabetes A Giongo, KA Gano, DB Crabb, N Mukherjee, LL Novelo, G Casella, ... The ISME journal 5 (1), 82-91, 2011 | 994 | 2011 |
An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes KC Herold, BN Bundy, SA Long, JA Bluestone, LA DiMeglio, MJ Dufort, ... New England Journal of Medicine 381 (7), 603-613, 2019 | 967 | 2019 |
Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes CT Brown, AG Davis-Richardson, A Giongo, KA Gano, DB Crabb, ... PloS one 6 (10), e25792, 2011 | 921 | 2011 |
Erratum: Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes SB Wilson, SC Kent, KT Patton, T Orban, RA Jackson, M Exley, S Porcelli, ... Nature 399 (6731), 84-84, 1999 | 844 | 1999 |
Identification of tissue-specific cell death using methylation patterns of circulating DNA R Lehmann-Werman, D Neiman, H Zemmour, J Moss, J Magenheim, ... Proceedings of the National Academy of Sciences 113 (13), E1826-E1834, 2016 | 653 | 2016 |
Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial T Orban, B Bundy, DJ Becker, LA DiMeglio, SE Gitelman, R Goland, ... The Lancet 378 (9789), 412-419, 2011 | 650 | 2011 |
Type 1 diabetes in children and adolescents: a position statement by the American Diabetes Association JL Chiang, DM Maahs, KC Garvey, KK Hood, LM Laffel, SA Weinzimer, ... Diabetes care 41 (9), 2026, 2018 | 564 | 2018 |
The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study JP Krischer, KF Lynch, DA Schatz, J Ilonen, Å Lernmark, WA Hagopian, ... Diabetologia 58, 980-987, 2015 | 508 | 2015 |
Functional Defects and the Influence of Age on the Frequency of CD4+CD25+ T-Cells in Type 1 Diabetes TM Brusko, CH Wasserfall, MJ Clare-Salzler, DA Schatz, MA Atkinson Diabetes 54 (5), 1407-1414, 2005 | 505 | 2005 |
Type 1 diabetes mellitus: etiology, presentation, and management MJ Haller, MA Atkinson, D Schatz Pediatric Clinics 52 (6), 1553-1578, 2005 | 492 | 2005 |
A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes WJ Riley, NK Maclaren, J Krischer, RP Spillar, JH Silverstein, DA Schatz, ... New England journal of medicine 323 (17), 1167-1172, 1990 | 434 | 1990 |
Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial DK Wherrett, B Bundy, DJ Becker, LA DiMeglio, SE Gitelman, R Goland, ... The Lancet 378 (9788), 319-327, 2011 | 424 | 2011 |
Insulitis and β-cell mass in the natural history of type 1 diabetes M Campbell-Thompson, A Fu, JS Kaddis, C Wasserfall, DA Schatz, ... Diabetes 65 (3), 719-731, 2016 | 407 | 2016 |
Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials A Moran, B Bundy, DJ Becker, LA DiMeglio, SE Gitelman, R Goland, ... The Lancet 381 (9881), 1905-1915, 2013 | 385 | 2013 |